Can prescription benefit managers, or PBMs, be eliminated from the U.S. drug pricing process? Seeking Alpha analysts weigh in. Read more here.

Humana has a P/E ratio of 16.4 based on its 12 month trailing earnings per share of $14.17. Considering its future earnings ...

UnitedHealth Group Incorporated's stock faces a steep decline amid leadership turmoil, regulatory pressures, and rising costs ...

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look ...

Humana Inc. closed 37.79% short of its 52-week high of $406.46, which the company reached on July 18th.

Leerink Partners analyst Whit Mayo reiterated a Hold rating on Humana (HUM – Research Report) yesterday and set a price target of $271.00. The company’s shares closed yesterda ...

She currently oversees CNET Money's housing market coverage ... When shopping for a new mortgage, it's important to compare not just mortgage rates but also closing costs and any other fees ...

She currently oversees CNET Money's housing market coverage ... It’s also important to compare options from multiple lenders. In addition to scoring the lowest rate, shopping around can help ...

Humana's HUM +1.79% + Free Alerts short percent of float has fallen 14.71% since its last report. The company recently reported that it has 3.12 million shares sold short, which is 2.9% of all regular ...

(RTTNews) - Shares of Humana, Inc. were gaining around 7 percent in the pre-market activity on the NYSE after the health insurer on Wednesday reported higher first-quarter profit above market ...